Probiotics (living agents) & Non-Alcoholic Fatty Liver Disease (NAFLD) / Metabolic dysfunction-associated fatty liver disease (MAFLD)

Some probiotics have been shown to improve liver parameters and phenotype in patients with NAFLD. Their oral intake might become an effective management strategy for the prevention and treatment of NAFLD (1). Research suggests that probiotics may have beneficial immunoregulatory effects in the treatment of NAFLD. These effects include modulating the intestinal microbiota, enhancing epithelial barrier function, and strengthening the intestinal wall to decrease its permeability. Additionally, probiotics can reduce bacterial translocation and endotoxemia, improve [intestinal inflammation](brain://BzW6blFRg06hY4CJBJ…